
📢Amplifying Patient Voices in Neuroendocrine Carcinoma Research We're proud to have collaborated on the VOICE Study, presented at #esmo26 and #NANETS2026, highlighting the experiences, challenges, and unmet needs of people affected by extrapulmonary neuroendocrine carcinoma (epNEC), meaning neuroendocrine carcinoma that originates outside the lungs. The study surveyed 226 patients across the U.S., revealing important insights: 🔷 54% waited more than a month after symptoms began before seeking medical attention. 🔷 Patients reported significant impacts on their physical health, emotional well-being, and daily activities. 🔷 94% were willing to undergo biomarker testing to help guide treatment decisions. 🔷 Key unmet needs include greater access to specialists and novel therapies, more treatment options and educational resources, and greater involvement in treatment decisions. NCF's Director of Programs & Outreach, Lisa Yen, was honored to help present this important research at #NANETS2026. We're grateful to @AmanChauhanMD, Dr. Jason Starr, @Boehringer, and our fellow patient advocacy organizations for their collaboration. Most importantly, thank you to every patient, care partner, and HCP who shared their experiences. Your voices are helping shape the future of NEC care. Together, we're working toward greater awareness, better access to care, and improved outcomes for the NEC community. Read the full blog post here: ncf.net/post/amplifying-pati… @HealingNET1 @NANETS1 @CureNETs @netcanceraware #NeuroendocrineCancer #Neuroendocrinecarcinoma #epnec #voicestudy #nanets2026 #ESMO2026 #PatientAdvocacy #ncfcancer
















